NERVI, Clara
 Distribuzione geografica
Continente #
NA - Nord America 5.355
EU - Europa 2.165
AS - Asia 948
SA - Sud America 68
AF - Africa 31
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.575
Nazione #
US - Stati Uniti d'America 5.319
IT - Italia 598
SE - Svezia 409
DE - Germania 371
SG - Singapore 337
IN - India 294
FI - Finlandia 238
CN - Cina 233
UA - Ucraina 218
GB - Regno Unito 81
RU - Federazione Russa 68
FR - Francia 47
BR - Brasile 34
AR - Argentina 33
CA - Canada 29
IE - Irlanda 23
NL - Olanda 21
RO - Romania 21
BG - Bulgaria 19
BE - Belgio 17
ID - Indonesia 17
IR - Iran 14
JP - Giappone 14
AT - Austria 13
TG - Togo 10
HK - Hong Kong 9
TR - Turchia 9
MX - Messico 6
ZA - Sudafrica 6
DK - Danimarca 5
PL - Polonia 5
TW - Taiwan 5
AU - Australia 4
CH - Svizzera 4
NZ - Nuova Zelanda 3
BD - Bangladesh 2
EG - Egitto 2
ET - Etiopia 2
GH - Ghana 2
IL - Israele 2
JO - Giordania 2
MA - Marocco 2
MG - Madagascar 2
MU - Mauritius 2
PK - Pakistan 2
PT - Portogallo 2
TH - Thailandia 2
AL - Albania 1
BZ - Belize 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
IQ - Iraq 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LT - Lituania 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
QA - Qatar 1
SC - Seychelles 1
TN - Tunisia 1
Totale 8.575
Città #
Fairfield 830
Woodbridge 511
Ashburn 410
Houston 356
Chandler 348
Seattle 319
Wilmington 259
Ann Arbor 244
Cambridge 232
Rome 232
Singapore 217
San Paolo di Civitate 166
Beijing 157
Princeton 154
Plano 132
Lawrence 115
Helsinki 108
Boston 106
Jacksonville 80
San Diego 66
New York 61
Des Moines 57
Dearborn 56
Santa Clara 56
Millbury 49
Andover 38
Boardman 34
Federal 33
Pune 31
Bremen 26
Milan 23
Dublin 22
Southend 22
Norwalk 21
Falls Church 19
Sofia 19
Toronto 18
Brussels 17
Fremont 17
Jakarta 16
Mannheim 12
Bühl 11
Falkenstein 11
Indiana 11
Moscow 11
Lomé 10
Ottawa 10
Los Angeles 9
Dallas 8
Hefei 8
Shanghai 8
Vienna 8
Groningen 7
Hangzhou 7
San Mateo 7
Alcamo 6
Auburn Hills 6
Bolzano Vicentino 6
Buffalo 6
Florence 6
Kunming 6
London 6
Redmond 6
Sabaudia 6
San Jose 6
Tokyo 6
Delhi 5
Jinan 5
Muizenberg 5
Padova 5
Redwood City 5
Tappahannock 5
Tehran 5
Gaeta 4
Las Vegas 4
Palermo 4
Palo Alto 4
Phoenix 4
Shizuoka 4
Bursa 3
Central 3
Chiswick 3
Greifswald 3
Nanchang 3
Paris 3
Pisa 3
Salzkotten 3
São Paulo 3
Aarhus 2
Accra 2
Addis Ababa 2
Auckland 2
Benxi 2
Bern 2
Brentford 2
Brisbane 2
Changsha 2
Chengdu 2
Genova 2
Genzano Di Roma 2
Totale 5.991
Nome #
ACETYLCHOLINE MAY REGULATE ITS OWN NICOTINIC RECEPTOR-CHANNEL THROUGH THE C-KINASE SYSTEM 129
ISTOLOGIA di Monesi 123
AVP induces myogenesis through the transcriptional activation of the myocyte enhancer factor 2 122
Protein kinase C in cell proliferation and differentiation 108
Activity and regulation of calcium-, phospholipid- dependent protein kinase in differentiating chick myogenic cells 107
Proliferating and quiescent cells exhibit different subcellular distribution of protein kinase C activity 103
Retinoic acid receptors. From molecular mechanisms to cancer therapy 96
Acetylcholine stimulates phosphatidylinositol turnover at nicotinic receptors of cultured myotubes 94
Vasopressin-dependent myogenic cell differentiation is mediated by both Ca2+/calmodulin-dependent kinase and calcineurin pathways 93
Genetic lesions disrupting calreticulin 3′-untranslated region in JAK2 mutation-negative polycythemia vera 92
Studies on the mechanism of the mitotic response to tumor promoters and growth factors 91
MicroRNAs and Hematopoietic Differentiation 90
Transcriptional targeting by microRNA-Polycomb complexes A novel route in cell fate determination 89
A 3-D Microdosimetric Study on Blood Cells: A Permittivity Model of Cell Membrane and Stochastic Electromagnetic Analysis 87
Nuclear miR-223 affects chromatin organization and regulates Flotillin-1 gene expression in myeloid progenitors 86
A Microwave Microdosimetric Study on Blood Cells: Estimation of Cell Membrane Permittivity and Parametric EM Analysis 86
Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells 86
Constitutive degradation of PML/RARa through the proteasome pathway mediates retinoic acid resistance 85
POLYCLONAL HEMATOPOIETIC RECONSTITUTION IN LEUKEMIA PATIENTS AT REMISSION AFTER SUPPRESSION OF SPECIFIC GENE REARRANGEMENTS 85
Epigenetic treatment of solid tumours. A review of clinical trials 84
Acute promyelocytic leukemia: a curable disease 84
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway 83
La rigenerazione del muscolo scheletrico nei topi è stimolata dalla iperespressione locale del recettore V1a della vasopressina 79
A novel epigenetic AML1-ETO/THAP10/miR-383 mini-circuitry contributes to t(8;21) leukaemogenesis 79
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34+ progenitors and CML cells 79
AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transactivation 79
Targeting of the N-terminal coiled coil oligomerization interface by a Helix-2 peptide inhibits unmutated and imatinib-resistant BCR/ABL 78
Retinoic acid receptors as regulators of human epidermal keratinocyte differentiation. 78
Altered protein phosphorylation in murine muscular dystrophy 78
Targeting of the N-terminal coiled coil oligomerization interface of BCR interferes with the transformation potential of BCR-ABL and increases sensitivity to STI571 78
Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression 78
HDAC inhibition by valproic acid decreases JAK2V617F levels in myeloproliferative neoplasms via up-regulation of miR-101, in vivo and in vitro 78
ARGININE-VASOPRESSIN INDUCES DIFFERENTIATION OF SKELETAL MYOGENIC CELLS AND UP-REGULATION OF MYOGENIN AND MYF-5 77
Transcriptional fine-tuning of microRNA-223 levels directs lineage choice of human hematopoietic progenitors 77
Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo 77
Emerging role for microRNAs in acute promyelocytic leukemia 75
Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia 74
The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARα 74
Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells 73
Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming 73
Epigenetic role of miRNAs in normal and leukemic hematopoiesis 73
Altered ligand binding and transcriptional regulation by mutations in the PML/RARa ligand binding domain arising in retinoic acid resistant patients with acute promyelocytic leukemia 73
The 12th international conference on differentiation therapy: Targeting the aberrant growth, differentiation and cell death programs of cancer cells 73
A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RARa mutation 72
Skeletal Muscle Regeneration in Mice Is Stimulated by Local Overexpression of V1a-Vasopressin Receptor 72
Are DNA damage response kinases a target for the differentiation treatment of acute myeloid leukemia? 72
Role of NFIB in normal hematopoiesis and MyeloproliferativeNeoplasms 71
Exposure of normal and transformed cells to nevirapine, a reverse transcriptase inhibitor, reduces cell growth and promotes differentiation 70
Complete remission through blast cell differentiation in PLZF/RARalpha-positive acute promyelocytic leukemia: in vitro and in vivo studies 70
Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines 70
Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway 70
Cell Dynamics in Early Embryogenesis and Pluripotent Embryonic Cell Lines: From Sea Urchin to Mammals 70
NFI-A directs the fate of hematopoietic progenitors to the erythroid or granulocytic lineage and controls β-globin and G-CSF receptor expression 70
Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation 68
Dielectric spectroscopy of blood cells suspensions: Study on geometrical structure of biological cells 68
A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. 68
A complete remission induced by valproic acid in a patient with essential thrombocytemia JAKV617F- positive 68
Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias 67
Regulation of skeletal muscke differentiation by arginine-vasopressin 65
AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia 65
A highly specific q-RT-PCR assay to address the relevance of the JAK2WT and JAK2V617F expression levels and control genes in Ph-negative myeloproliferative neoplasms 65
A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia 65
PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity 65
Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells 64
Sequential Valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia. 64
NFI-A DIRECTS THE FATE OF HEMATOPOIETIC PROGENITORS TO THE ERYTHROID OR GRANULOCYTIC LINEAGE AND CONTROLS b-GLOBIN AND G-CSF RECEPTOR EXPRESSION 64
Isolation and binding characteristics of nuclear retinoic acid receptors. 63
Oncoproteins, heterochromatin silencing and microRNAs: A new link for leukemogenesis 62
Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells. 62
Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor 62
Vasopressin and insulin-like growth factors synergistically induce myogenesis in serum-free medium 60
Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia 59
Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status 59
Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases 59
The gene promoter binding activity of miR-223 induces flotillin-1 expression and function to regulate myeloid differentiation 59
Aptamer-based technology for radionuclide targeted imaging and therapy. A promising weapon against cancer 58
Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells 57
Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARa-mediated increase of type II transglutaminase 57
A novel germline mutation in the 3'Untranslated region of Calreticulin gene induces JAK/STAT signaling activation and Erythrocytosis. 57
Molecular imaging in immuno-oncolog. Current status and translational perspectives 57
Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leucemia. 56
A novel germline CALR mutation affecting an evolutionary conserved region of 3’UTR in JAK2-negative siblings with Polycythemia Vera 56
Regulation of type I and type II transglutaminase in normal human bronchial epithelial and lung carcinoma cells. 55
Polycomb/Trithorax proteins regulate NFIA expression during normal and leukemic hematopoiesis 55
Expression of SMRT{beta} promotes ligand-induced activation of mutated and wild-type retinoid receptors 54
MicroRNA: Basic mechanisms and transcriptional regulatory networks for cell fate determination 54
The epigenetic/transcriptional activity of nuclear mir-223 regulates flotillin-1 expression and function in myeloid differentiation 54
Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. 53
Homeobox 1.3 expression: induction by retinoic acid in human bronchial fibroblasts. 53
Ruxolitinib binding to human serum albumin. Bioinformatics, biochemical and functional characterization in JAK2V617F+ cell models 53
AML-associated translocation products block vitamin D(3)-induced differentiation by sequestering the vitamin D(3) receptor 51
Positive and negative regulation of proliferation and differentiation in tracheobronchial epithelial cells. 51
Hyperplasia and squamous metaplasia in the tracheobronchial epithelium: alterations in the balance of growth and differentiation factors. 51
MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks 51
Histone deacetylases: A common molecular target for differentiation treatment of acute myeloid leukemias? 51
Epigenetics in focus: Pathogenesis of myelodysplastic syndromes and the role of hypomethylating agents 51
Identification and characterization of nuclear retinoic acid-binding activity in human myeloblastic leukemia HL-60 cells. 51
Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alfa protein in acute promyelocytic leukemia cells 50
Eicosapentaenoic acid modulates the synergistic action of CREB1 and ID/E2A family members in the rat pup brain and mouse embryonic stem cells 50
Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response 49
Totale 7.149
Categoria #
all - tutte 25.344
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.344


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020917 0 0 0 0 0 0 205 199 183 139 134 57
2020/2021573 58 68 18 49 18 42 48 70 66 78 47 11
2021/20221.657 15 105 135 177 181 62 31 155 111 148 196 341
2022/20231.510 299 412 77 171 126 158 19 78 98 9 45 18
2023/2024767 44 80 24 57 52 151 16 116 6 63 88 70
2024/2025625 93 51 93 122 130 134 2 0 0 0 0 0
Totale 8.776